Archive for the ‘Africa’ category

Trypanosomes, climate change and evolution; past and present

December 14th, 2011

By: Charles Ebikeme

“Trypanosomiasis has kept Africa green…”

The quote above comes from a book I can’t remember by an author whose name escapes me. In essence, it alludes to the inextricable relationship and balance that exists between all things on our planet, particularly the relationship between man and his environment. For a long time, we have known about the influence diseases can have on us, but we are only now beginning to realise its full extent.

The delicate relationship and inter-connected influence between human populations, climate, and the ecology of disease (vector-borne or otherwise) has unfolded over evolutionary time.

Photo credit: Britannica Encyclopedia

Genetically, some populations are predisposed to particular diseases. A study published in Science last year, showed  African-Americans have higher rates of kidney disease than European-Americans. The reason, as postulated by the researchers, was due to variants of a gene (APOL1), common in African chromosomes but absent from European chromosomes. The gene codes for a serum factor that lyses (or harms) trypanosomes. It seems the evolution of a critical survival factor in Africa now contributes to the high rates of kidney disease in African-Americans.

Changes in African climate in the last 5-6 million years are thought to have mediated important modifications in the African environment and in the animals that live there. As the rivers changed, and as plant and animal species adapted to a changing climate, disease was brought to areas where it wasn’t before. These phenomena have marked important milestones in the evolution of humans and their predecessors. » Read more: Trypanosomes, climate change and evolution; past and present

Merck Serono Helps Eliminate Schistosomiasis in Africa

December 13th, 2011

Merck Serono plans to double its donation from 25 million tablets to 50 million tablets and will continue a commitment to donations indefinitely, until schistosomiasis has been eliminated in Africa. In a press statement released today, Merck Serono said that in addition to doubling their annual donation of praziquantel, they will financially support a World Health Organization (WHO)-led school-awareness program in Africa aimed at preventing the occurrence of schistosomiasis.

“Together with WHO, we want to help to successfully fight this insidious tropical disease,” said Stefan Oschmann, Executive Board Member of Merck KGaA and President of Merck Serono.

You can read more about Merck Serono’s commitment to eliminate Schistosomiasis in their press release, linked here.

Visceral leishmaniasis/HIV co-infection in East Africa

December 8th, 2011

By: Julien Potet, Neglected Tropical Diseases Policy Advisor at Médecins Sans Frontières’ Campaign for Access to Essential Medicines

Today is the last day of the 16th International Conference on AIDS and STIs in Africa (ICASA), in Addis Ababa, Ethiopia. Ethiopia is a hotspot for cases of co-infection between HIV and visceral leishmaniasis: around one-third of patients with visceral leishmaniasis in North-West Ethiopia are also HIV-positive. With ICASA this year being held in the heart of where most cases of HIV and visceral leishmaniasis occur, it presents a unique opportunity to highlight both the danger of visceral leishmaniasis among the HIV community, and the measures to be taken to address this deadly co-infection.

Visceral leishmaniasis endemic areas in East Africa.

Visceral leishmaniasis, also known as kala azar, is a vector-borne neglected parasitic disease that is fatal if left untreated. It affects between 250,000 and 300,000 people each year worldwide. In East Africa, cases of visceral leishmaniasis are driven by many factors, including the weakness of health systems, the displacement of non-immune populations and the HIV pandemic.

Visceral leishmaniasis can not be fully cured in people living with HIV in East Africa. Relapses are almost inevitable and people living with HIV become more drug-unresponsive with each subsequent relapse. But successful treatment of the first episode of visceral leishmaniasis and early initiation of antiretroviral therapy may delay and reduce relapses. Medecins Sans Frontieres (MSF) has found that customised treatment for visceral leishmaniasis in HIV-positive people can improve their survival rates over time. » Read more: Visceral leishmaniasis/HIV co-infection in East Africa

New (problem) kids on the block: Neglected Tropical Diseases

December 7th, 2011

In Kenya, neglected tropical diseases (NTDs) are continually gaining more attention. With a recently launched five-year national plan to rid the country of NTDs and focused efforts on eliminating trachoma, the Kenyan government is working tirelessly to advocate for and treat the 1 in 2 Kenyans who suffer needlessly at the hands of NTDs. Below is an excerpt of an article published on AllAfrica.com, the largest electronic distributor of African news and information, that describes the burden of NTDs in Kenya,  as well as identifying NTDs as one of the next major issues in global health:

Global Network Senior Resource Development Officer Valerie Fitton-Kane distributes Abendazole at Kahawa West Primary School in Nairobi, Kenya.

For years, HIV/AIDS has caused the government a lot of worry — and with good reason. From the time it was declared a national disaster, there have been numerous campaigns to sensitise the public, drowning Kenyans in information. Today, it is almost impossible to find anyone in Kenya who does not know anything about HIV/AIDS.

But now there is a new problem kid on the block: neglected tropical diseases. These are a group of chronic diseases with serious consequences that affect populations living in low-income rural areas of Africa, Asia, and the Americas. It is for this reason that neglected tropical diseases are also known as the diseases of the poor. The World Health Organisation (WHO) estimates that at least one billion people are infected with neglected tropical diseases. In Kenya, about 50 per cent of the total population is infected with at least one neglected tropical disease. This has prompted the government to start to shift uncomfortably — having half the population sick does not exactly sit well on the road map to achieving Vision 2030. The Ministry of Public Health and Sanitation has, therefore, embarked on a mission to fight the diseases. Click here to continue reading.